EPIZYME, INC. Marketable Securities (Current)
EPIZYME, INC. had Marketable Securities (Current) of $73.35 million as of 2022-06-30, per its 10-Q filed 2022-08-09.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:MarketableSecuritiesCurrent · last filed 2022-08-09
- 2022-06-30: Marketable Securities, Current $73.35M.
- 2022-03-31: Marketable Securities, Current $122.31M.
- 2021-12-31: Marketable Securities, Current $78.45M.
- 2021-09-30: Marketable Securities, Current $96.78M.
| Period end | Marketable Securities, Current |
|---|---|
| 2022-06-30 | $73.35M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $122.31M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $78.45M 10-Q · filed 2022-08-09 |
| 2021-09-30 | $96.78M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $163.84M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $225.23M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $205.39M 10-K · filed 2022-03-01 |
| 2020-09-30 | $186.49M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $204.91M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $197.20M 10-Q · filed 2020-05-04 |
| 2019-12-31 | $241.60M 10-K · filed 2021-02-23 |
| 2019-09-30 | $199.40M 10-Q · filed 2019-10-31 |
| 2019-06-30 | $285.05M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $226.84M 10-Q · filed 2019-05-06 |
| 2018-12-31 | $153.63M 10-K · filed 2020-02-27 |
| 2018-09-30 | $114.50M 10-Q · filed 2018-11-02 |
| 2018-06-30 | $147.72M 10-Q · filed 2018-08-02 |
| 2018-03-31 | $117.63M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $49.77M 10-K · filed 2019-02-26 |
| 2017-09-30 | $87.43M 10-Q · filed 2017-11-01 |
| 2017-06-30 | $104.47M 10-Q · filed 2017-08-07 |
| 2017-03-31 | $146.77M 10-Q · filed 2017-05-08 |
| 2016-12-31 | $164.30M 10-K · filed 2018-03-13 |
| 2016-09-30 | $197.31M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $199.14M 10-Q · filed 2016-08-08 |